Developer docs
API playgroundTry for free, no card

Search company profiles

Metaoptima

Full company profile

uuid0002px6

Namestring
Metaoptima
Legal namestring
MetaOptima Technology Inc.
Websiteurl
metaoptima.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

MetaOptima Technology Inc. is a Vancouver-based private digital health and medical device company founded in 2012 by CEO Maryam Sadeghi, PhD and CTO Majid Razmara, PhD. The company develops AI-powered dermatology imaging and analytics solutions spanning the full skin-care workflow from patient self-monitoring to clinical diagnosis. Its three core products are DermEngine, a cloud-based skin imaging and analytics platform with EMR/EHR integration used by dermatologists and medical professionals; OptimaScan, an AI-powered 3D total body photography system with a 360-degree rotating arm, 48MP image capture resolution, and sub-1-minute full-body scan times; and MoleScope, a consumer-grade mobile dermatoscope paired with a smartphone app that enables patients and primary care providers to capture dermoscopic images. The integrated platform combines proprietary computer vision and machine learning algorithms for automated skin disease detection, lesion analysis, and skin cancer screening, with a growing dataset of dermoscopy images serving as a continuous improvement flywheel.

MetaOptima generates revenue through three streams: hardware sales of OptimaScan and MoleScope devices, subscription-based access to the DermEngine platform for medical professionals (sold on annual quote-based contracts), and platform licensing of DermEngine capabilities to healthcare institutions. The go-to-market combines enterprise field sales to hospitals, clinics, and dermatology practices with direct-to-consumer distribution of MoleScope through app stores, supplemented by strong event-driven marketing at major dermatology conferences (MEDICA, EADV, AAD, ATA Nexus, Australasian Skin Cancer Congress, American Dermoscopy Meeting). The company operates through its Canadian parent entity and a wholly-owned Australian subsidiary (MetaOptima Technology Australia Pty Ltd), serving markets in Canada, the United States, Australia, and New Zealand. Recent strategic activity has emphasized Australia and New Zealand expansion through partnerships with the Digital Health & Discovery Platform (DHDP), Skin Check Champions, and Skin Cancer College.

MetaOptima has raised approximately $8.5 million+ in disclosed funding across venture and non-dilutive sources, including a $6.5 million round led by Airtree Ventures and Skip Capital in 2018 and approximately $2.03 million CAD from PacifiCan and Circle Innovation's BC Healthtech SME Program in 2023. The company employs approximately 30 people across engineering, machine learning/AI, sales, regulatory, and operations roles, and has been recognized as an ATA 2024 Nexus Telehealth Innovators Challenge Finalist for DermEngine's AI-powered care coordination.

Short descriptiontext

MetaOptima Technology Inc. is a Vancouver-based digital health company founded in 2012 that develops AI-powered dermatology imaging solutions, including the DermEngine analytics platform, OptimaScan 3D total body photography system, and MoleScope mobile dermatoscope, serving dermatologists, healthcare institutions, and patients globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI dermatology imaging, skin cancer screening, teledermatology platform, dermoscopy devices, medical imaging analytics
Industry2 codes
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLALAGAA
Dermatology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Prepackaged Software7372
Product category
Dermatology Imaging & Analytics Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Sales
TypeHardware Sales
Description

Sale of OptimaScan and MoleScope imaging devices to healthcare providers and patients

metaoptima.com
2Software Subscriptions
TypeSubscription Recurring
Description

Subscription-based access to DermEngine platform for medical professionals with tiered features for imaging, analytics, and EMR/EHR integration

metaoptima.com
3Platform Licensing
TypeLicensing Royalties
Description

Licensing of DermEngine platform capabilities to healthcare institutions and partners for integration into their workflows

metaoptima.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Pricing details1 tier
1Enterprise healthcare institution pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed

metaoptima.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 3 records shown
1OptimaScan
Description

AI-Powered 3D Total Body Photography system with 360° rotating arm, 48MP capture, and seamless DermEngine integration for full-body imaging in under 1 minute.

metaoptima.com
+2 more records
Core offering1 text field

MetaOptima develops and sells AI-powered dermatology imaging and analytics solutions built around three integrated products: DermEngine, a cloud-based platform for skin imaging, AI-assisted analysis, and EMR/EHR-integrated documentation used by medical professionals; OptimaScan, an AI-powered 3D total body photography system with 360° rotating arm and 48MP capture; and MoleScope, a smartphone-connected dermatoscope and app for patient skin monitoring and tele-dermatology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Full-body imaging in under 1 minute with 360° rotation and 48MP capture resolution
+2 more records
Product overview1 text field

MetaOptima offers an integrated multi-product platform for intelligent dermatology consisting of three core products: OptimaScan (AI-powered 3D total body photography device with 48MP resolution), DermEngine (cloud-based skin imaging and analytics platform for medical professionals), and MoleScope (mobile dermatoscope and app for patients). These products work together as an ecosystem where OptimaScan and MoleScope capture skin images which are then analyzed by DermEngine's AI-powered analytics platform for skin disease detection and management.

Product and service3 records
1OptimaScan
CategoryMedical Imaging Hardware
Description

AI-Powered 3D Total Body Photography hardware system with a 360° rotating arm, 48MP image capture, and scan time under 1 minute, designed for clinical full-body skin imaging with seamless DermEngine integration for AI-powered skin analysis. Targeted at healthcare institutions, hospitals, and dermatology practices.

2DermEngine
CategoryDermatology Analytics Software
Description

Cloud-based platform for skin imaging, AI-powered skin analysis, and clinical documentation with EMR/EHR integration. Provides intelligent dermatology workflows, lesion analysis, teledermatology, and AI-powered care coordination for medical professionals and healthcare institutions.

3MoleScope
CategoryConsumer Skin Imaging Device
Description

Affordable smartphone-connected dermatoscope device and companion mobile app that enables patients and consumers to capture dermoscopic images for personal skin monitoring, mole tracking, and tele-dermatology consultations with healthcare providers.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-07
Description

Partnership to expand access to skin cancer detection in Australia, bringing advanced skin checks to communities outside major cities using OptimaScan's mobile 3D Total Body Photography system.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-11-20
Description

Hosted exclusive roundtable event at New Zealand Parliament where ministers and officials received professional skin checks using DermEngine as part of skin cancer awareness activities.

3Skin Check Champions
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-22
Description

Pioneering the world's first targeted, AI-assisted and nurse-led skin check program in Australia. MetaOptima provides DermEngine and OptimaScan technology to enable community-based skin cancer screening for underserved populations in Australia.

metaoptima.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based AI dermatology company focused on skin cancer detection with regulatory-cleared deep learning models used in NHS pathways. Direct comparable in AI-powered skin lesion triage and clinical dermatology workflows.

TypeDirect peer
Description

Amsterdam-based company offering a smartphone app for AI-powered skin cancer risk assessment with consumer and clinician-facing tiers. Closely comparable to MoleScope plus DermEngine as an integrated consumer/professional dermatology AI platform.

TypeDirect peer
Description

US-based developer of a handheld, FDA-cleared AI-powered spectroscopy device for primary-care skin cancer detection. Directly comparable as a hardware-plus-AI dermatology diagnostic aimed at non-dermatologist clinicians.

TypeDirect peer
Description

German manufacturer of total body photography and AI-assisted dermoscopy systems widely used by dermatologists. Direct competitor to OptimaScan in the enterprise 3D body imaging hardware segment.

TypeBroad incumbent
Description

Established US-based provider of medical imaging systems for dermatology, aesthetics, and plastic surgery with broad hardware/software portfolios. Comparable to MetaOptima's OptimaScan plus DermEngine for dermatology practices, but at much larger scale and broader scope.

TypeDirect peer
Description

Australia and New Zealand skin cancer screening service combining dermoscopy, dermatologist review, and longitudinal mole monitoring. Operates in the same APAC geographies as MetaOptima's Australian and NZ deployments.

TypeDirect peer
Description

Teledermatology platform offering asynchronous dermatologist consultations via a smartphone app. Comparable to the consumer MoleScope + DermEngine teledermatology workflow.

TypeBroad incumbent
Description

Google's AI dermatology assistant offering condition-matching from smartphone photos, integrated with Search. Functions as a broad incumbent that competes for the same clinical decision-support and patient-facing dermatology AI workflows as DermEngine and MoleScope.

TypeEmerging player
Description

EU-based AI dermatology app providing skin condition and risk assessment via smartphone, with a clinician-facing API. Comparable to MoleScope as a consumer/clinical skin analysis tool, with overlapping teledermatology applications.

103Derm Systems
TypeEmerging player
Description

US-based teledermatology hardware and software provider for primary care and remote skin triage. Comparable as a combined imaging-device-plus-platform solution aimed at non-dermatologist clinicians, similar to MetaOptima's enterprise positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Metaoptima

Dermatology Imaging & Analytics Softwaremetaoptima.com

MetaOptima Technology Inc. is a Vancouver-based digital health company founded in 2012 that develops AI-powered dermatology imaging solutions, including the DermEngine analytics platform, OptimaScan 3D total body photography system, and MoleScope mobile dermatoscope, serving dermatologists, healthcare institutions, and patients globally.

What Metaoptima does

MetaOptima Technology Inc. is a Vancouver-based private digital health and medical device company founded in 2012 by CEO Maryam Sadeghi, PhD and CTO Majid Razmara, PhD. The company develops AI-powered dermatology imaging and analytics solutions spanning the full skin-care workflow from patient self-monitoring to clinical diagnosis. Its three core products are DermEngine, a cloud-based skin imaging and analytics platform with EMR/EHR integration used by dermatologists and medical professionals; OptimaScan, an AI-powered 3D total body photography system with a 360-degree rotating arm, 48MP image capture resolution, and sub-1-minute full-body scan times; and MoleScope, a consumer-grade mobile dermatoscope paired with a smartphone app that enables patients and primary care providers to capture dermoscopic images. The integrated platform combines proprietary computer vision and machine learning algorithms for automated skin disease detection, lesion analysis, and skin cancer screening, with a growing dataset of dermoscopy images serving as a continuous improvement flywheel.

MetaOptima generates revenue through three streams: hardware sales of OptimaScan and MoleScope devices, subscription-based access to the DermEngine platform for medical professionals (sold on annual quote-based contracts), and platform licensing of DermEngine capabilities to healthcare institutions. The go-to-market combines enterprise field sales to hospitals, clinics, and dermatology practices with direct-to-consumer distribution of MoleScope through app stores, supplemented by strong event-driven marketing at major dermatology conferences (MEDICA, EADV, AAD, ATA Nexus, Australasian Skin Cancer Congress, American Dermoscopy Meeting). The company operates through its Canadian parent entity and a wholly-owned Australian subsidiary (MetaOptima Technology Australia Pty Ltd), serving markets in Canada, the United States, Australia, and New Zealand. Recent strategic activity has emphasized Australia and New Zealand expansion through partnerships with the Digital Health & Discovery Platform (DHDP), Skin Check Champions, and Skin Cancer College.

MetaOptima has raised approximately $8.5 million+ in disclosed funding across venture and non-dilutive sources, including a $6.5 million round led by Airtree Ventures and Skip Capital in 2018 and approximately $2.03 million CAD from PacifiCan and Circle Innovation's BC Healthtech SME Program in 2023. The company employs approximately 30 people across engineering, machine learning/AI, sales, regulatory, and operations roles, and has been recognized as an ATA 2024 Nexus Telehealth Innovators Challenge Finalist for DermEngine's AI-powered care coordination.

Metaoptima firmographics

Firmographics
Name
Metaoptima
Legal name
MetaOptima Technology Inc.
Website
https://metaoptima.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
MetaOptima Technology Inc. is a Vancouver-based digital health company founded in 2012 that develops AI-powered dermatology imaging solutions, including the DermEngine analytics platform, OptimaScan 3D total body photography system, and MoleScope mobile dermatoscope, serving dermatologists, healthcare institutions, and patients globally.
Ownership category
akta.pro rank

Metaoptima industry classification

Industry
Product category
Dermatology Imaging & Analytics Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLALAGAA
Dermatology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • AI dermatology imaging
  • Skin cancer screening
  • Teledermatology platform
  • Dermoscopy devices
  • Medical imaging analytics

Where Metaoptima is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Metaoptima business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. Hardware Sales: Sale of OptimaScan and MoleScope imaging devices to healthcare providers and patients
  2. Software Subscriptions: Subscription-based access to DermEngine platform for medical professionals with tiered features for imaging, analytics, and EMR/EHR integration
  3. Platform Licensing: Licensing of DermEngine platform capabilities to healthcare institutions and partners for integration into their workflows

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise healthcare institution pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Metaoptima product offering

Product offering

Core offering

MetaOptima develops and sells AI-powered dermatology imaging and analytics solutions built around three integrated products: DermEngine, a cloud-based platform for skin imaging, AI-assisted analysis, and EMR/EHR-integrated documentation used by medical professionals; OptimaScan, an AI-powered 3D total body photography system with 360° rotating arm and 48MP capture; and MoleScope, a smartphone-connected dermatoscope and app for patient skin monitoring and tele-dermatology.

Product overview

MetaOptima offers an integrated multi-product platform for intelligent dermatology consisting of three core products: OptimaScan (AI-powered 3D total body photography device with 48MP resolution), DermEngine (cloud-based skin imaging and analytics platform for medical professionals), and MoleScope (mobile dermatoscope and app for patients). These products work together as an ecosystem where OptimaScan and MoleScope capture skin images which are then analyzed by DermEngine's AI-powered analytics platform for skin disease detection and management.

Differentiator

Problem solved

Functional benefit

Brands

  • OptimaScan: AI-Powered 3D Total Body Photography system with 360° rotating arm, 48MP capture, and seamless DermEngine integration for full-body imaging in under 1 minute.
  • DermEngine
  • MoleScope

Products and services

  • OptimaScan AI-Powered 3D Total Body Photography hardware system with a 360° rotating arm, 48MP image capture, and scan time under 1 minute, designed for clinical full-body skin imaging with seamless DermEngine integration for AI-powered skin analysis. Targeted at healthcare institutions, hospitals, and dermatology practices.
  • DermEngine Cloud-based platform for skin imaging, AI-powered skin analysis, and clinical documentation with EMR/EHR integration. Provides intelligent dermatology workflows, lesion analysis, teledermatology, and AI-powered care coordination for medical professionals and healthcare institutions.
  • MoleScope Affordable smartphone-connected dermatoscope device and companion mobile app that enables patients and consumers to capture dermoscopic images for personal skin monitoring, mole tracking, and tele-dermatology consultations with healthcare providers.

Quantifiable outcome

  • Full-body imaging in under 1 minute with 360° rotation and 48MP capture resolution
  • +2 more outcomes

Companies that use Metaoptima

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Metaoptima technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

Metaoptima partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Digital Health & Discovery Platform (DHDP)coreStrategic or Co-development Partner · 7 January 2026Partnership to expand access to skin cancer detection in Australia, bringing advanced skin checks to communities outside major cities using OptimaScan's mobile 3D Total Body Photography system.
  • Skin Cancer College (New Zealand)minorStrategic or Co-development Partner · 20 November 2025Hosted exclusive roundtable event at New Zealand Parliament where ministers and officials received professional skin checks using DermEngine as part of skin cancer awareness activities.
  • Skin Check ChampionscoreStrategic or Co-development Partner · 22 February 2024Pioneering the world's first targeted, AI-assisted and nurse-led skin check program in Australia. MetaOptima provides DermEngine and OptimaScan technology to enable community-based skin cancer screening for underserved populations in Australia.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Metaoptima competitors and assessment

Company assessment

Direct peers

  • Skin Analytics: UK-based AI dermatology company focused on skin cancer detection with regulatory-cleared deep learning models used in NHS pathways. Direct comparable in AI-powered skin lesion triage and clinical dermatology workflows.
  • SkinVision: Amsterdam-based company offering a smartphone app for AI-powered skin cancer risk assessment with consumer and clinician-facing tiers. Closely comparable to MoleScope plus DermEngine as an integrated consumer/professional dermatology AI platform.
  • DermaSensor: US-based developer of a handheld, FDA-cleared AI-powered spectroscopy device for primary-care skin cancer detection. Directly comparable as a hardware-plus-AI dermatology diagnostic aimed at non-dermatologist clinicians.
  • FotoFinder Systems: German manufacturer of total body photography and AI-assisted dermoscopy systems widely used by dermatologists. Direct competitor to OptimaScan in the enterprise 3D body imaging hardware segment.
  • MoleMap: Australia and New Zealand skin cancer screening service combining dermoscopy, dermatologist review, and longitudinal mole monitoring. Operates in the same APAC geographies as MetaOptima's Australian and NZ deployments.
  • First Derm: Teledermatology platform offering asynchronous dermatologist consultations via a smartphone app. Comparable to the consumer MoleScope + DermEngine teledermatology workflow.

Broad incumbents

  • Canfield Scientific: Established US-based provider of medical imaging systems for dermatology, aesthetics, and plastic surgery with broad hardware/software portfolios. Comparable to MetaOptima's OptimaScan plus DermEngine for dermatology practices, but at much larger scale and broader scope.
  • Google Health (DermAssist): Google's AI dermatology assistant offering condition-matching from smartphone photos, integrated with Search. Functions as a broad incumbent that competes for the same clinical decision-support and patient-facing dermatology AI workflows as DermEngine and MoleScope.

Emerging players

  • Skinive: EU-based AI dermatology app providing skin condition and risk assessment via smartphone, with a clinician-facing API. Comparable to MoleScope as a consumer/clinical skin analysis tool, with overlapping teledermatology applications.
  • 3Derm Systems: US-based teledermatology hardware and software provider for primary care and remote skin triage. Comparable as a combined imaging-device-plus-platform solution aimed at non-dermatologist clinicians, similar to MetaOptima's enterprise positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Metaoptima social profiles

Digital presence

Metaoptima financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Metaoptima leadership team

Management profile

Number of profiles

Profiles1 record

Metaoptima subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Metaoptima funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Metaoptima M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metaoptima

What does Metaoptima do?

MetaOptima develops and sells AI-powered dermatology imaging and analytics solutions built around three integrated products: DermEngine, a cloud-based platform for skin imaging, AI-assisted analysis, and EMR/EHR-integrated documentation used by medical professionals; OptimaScan, an AI-powered 3D total body photography system with 360° rotating arm and 48MP capture; and MoleScope, a smartphone-connected dermatoscope and app for patient skin monitoring and tele-dermatology.

Is Metaoptima a public or private company?

Metaoptima is a private company. It is classified as venture growth investor backed and is currently operating.

When was Metaoptima founded?

Metaoptima was founded in 2012. It employs 11 to 50 people.

Where is Metaoptima based?

Metaoptima is headquartered in Vancouver, Canada, in the North America region.

How does Metaoptima make money?

Three revenue lines are on record. Hardware Sales are the primary driver. The others are software Subscriptions and platform Licensing.

Who are Metaoptima's main competitors?

Direct peers on record are Skin Analytics, SkinVision, DermaSensor, FotoFinder Systems, MoleMap and First Derm. Broad incumbents are Canfield Scientific and Google Health (DermAssist). Emerging players are Skinive and 3Derm Systems.

Does Metaoptima have an API?

No public API is recorded for Metaoptima.

What industry is Metaoptima in?

Metaoptima's product category is Dermatology Imaging & Analytics Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLALAGAA, Dermatology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechRoundTop MedTech Startups In CanadaThe article discusses the MedTech startup scene in Canada, highlighting innovative firms working on AI, wearable tech, and virtual health platforms. It provides details on key startups such as MetaOptima, AlayaCare, PocketPills, Felix Health, Curetech e-Health, and DigiBiomics Inc., including their products, funding, and strategic focus.EIN PresswireArtificial Intelligence (AI)-Powered Dermatology Lesion Triaging Market Projected to Reach $3.39 Bn 31.9% CAGR by 2029The Business Research Company published a market report projecting the AI-powered dermatology lesion triaging market to grow from $0.85 billion in 2024 to $3.40 billion by 2029, representing a compound annual growth rate of 31.9%. Key growth drivers include the increasing incidence of skin cancer, rising demand for personalized medicine, and greater adoption of digital health solutions in healthcare settings. Major players identified in the market include Proscia Inc., SkinVision B.V., MetaOptima Technology Inc., DermaSensor Inc., and Enspecta Health Inc., which recently received FDA breakthrough device designation for its AI-based VIO Skin platform.ItransitionTelemedicine for Dermatology: 360 Overview & Adoption GuideThe article provides a comprehensive overview of telemedicine for dermatology, detailing operational models such as store-and-forward and live video consultations, along with essential technical capabilities like secure data management and EHR integration. It highlights specific implementations by entities including MetaOptima Technology and UConn Health to demonstrate how virtual care improves patient access and clinical efficiency. The text also outlines the benefits, limitations, and best practices for healthcare providers adopting teledermatology solutions.EmerjMachine Learning for Dermatology – 5 Current ApplicationsThis article provides an overview of emerging AI and machine learning applications in dermatology, categorized into skin image analysis and skincare treatment personalization. The global market for skin disease treatment technologies is projected to reach $20.4 billion in 2020, driven by a workforce shortage in dermatology amid rising skin cancer rates. Six companies are profiled as representative examples: SkinVision (Netherlands), SkinIO, MoleScope/MetaOptima (Canada), HelloAva, and PROVEN Beauty (all U.S.-based), covering their technologies, funding, pricing models, and clinical validation studies.GlobeNewswireLondon Drugs Pharmacists Trained on MetaOptima Technology Will Offer 10 Skin Check Clinics in June and JulyLondon Drugs Patient Care Pharmacists will offer one-on-one skin check appointments at select lower mainland stores starting June 15, using MetaOptima's MoleScope device. The clinics, partnered with La Roche-Posay and dermatologist Dr. Jason Rivers, aim to educate on sun protection and assess mole concerns. The initiative launches during Melanoma month.BetaKitCascadia was Vancouver's "Startup-Palooza"Vancouver's five accelerators and incubators hosted Cascadia, a startup event with over 300 attendees and 25 investment-ready startups. Five companies pitched, including BitLit, PrintToPeer, myBestHelper, MetaOptima, and Crowd Content. BitLit won a spot at the upcoming Cloud Factory event in Banff.